The Effect of the Atypical Antipsychotic Quetiapine in the Treatment of Postpartum Depressive Disorder With Psychotic Symptoms.

Trial Profile

The Effect of the Atypical Antipsychotic Quetiapine in the Treatment of Postpartum Depressive Disorder With Psychotic Symptoms.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 21 Jul 2011

At a glance

  • Drugs Quetiapine (Primary)
  • Indications Postnatal depression
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 30 Oct 2008 Status changed from recruiting to discontinued according to ClinicalTrials.gov record.
    • 10 Jun 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top